Karen Becker
Share |


Karen Becker 

Managing Director, Precision for Medicine

Karen M. Becker, PhD, joined Precision for Medicine in December 2012 as Managing Director of the Translational and Regulatory Sciences Practice, which was established to provide value-added scientific and regulatory solutions for development, marketing authorization, regulatory compliance, and stewardship of innovative healthcare products.

Dr. Becker is an industry leader with over 25 years of experience serving hundreds of clients in a broad range of therapeutic areas, focusing on scientific and regulatory services to companies operating at the intersection of science and public policy. Successful resolution of client matters is achieved through application of sound science, reliance on leading clinical and scientific expertise, and a commitment to outstanding quality and service.

Precision for Medicine is a unique development and commercialization services company that was engineered from inception to help innovators address the needs of the new, evolving healthcare market. Precision for Medicine provides a wide range of strategic services, including scientific and global regulatory strategy, market access and reimbursement planning, biorepository services, and companion diagnostic program management.

Prior to Precision for Medicine, Dr. Becker was President of IndigoBay Ventures LLC, a management consulting firm providing scientific and regulatory services to healthcare companies and investors. She was the Founder and Chief Executive Officer of Becker & Associates Consulting, Inc., a leading full-service scientific and regulatory affairs consulting firm, until its acquisition. She has published original research in pharmacology and drug development, numerous publications on FDA regulation, textbooks on the design of clinical trials for medical devices, and the PLI Medical Device Law and Regulation Answer Book. Dr. Becker is an Adjunct Associate Professor at Georgetown University, where she teaches public health policy and biotechnology management. She received a BS in Biological Chemistry from the University of Maryland at College Park, and a PhD in Pharmacology from the University of North Carolina School of Medicine.